COVID-19 / Acute Respiratory Distress Syndrome (ARDS) Services
Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. This is a novel (or new) coronavirus that has not previously been seen in humans which has a wide range of symptoms reported with certain patients experiencing shortness of breath or difficulty breathing.
-
Most popular related searches
Details
Stemedica is initiating a multisite FDA-approved clinical trial to study the use of mesenchymal stem cells for severe lung injury from COVID-19 or other pneumonia titled A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in patients with Severe Lung Injury due to COVID-19 or Other Infectious Pathogens.
Customer reviews
No reviews were found for COVID-19 / Acute Respiratory Distress Syndrome (ARDS) Services. Be the first to review!